If approved by the FDA, the Acclaim would be the first-of-its-kind cochlear implant designed to be fully implanted and use the ear, rather than a microphone, to pick up sound notes Envoy Medical.
Radicle Science reports results demonstrated clinically meaningful improvements in pain across the different formulations of CBD and rare cannabinoids studied.
The study will evaluate the safety and efficacy of Neuspera's Nuvella system designed to treat overactive bladder (OAB) for patients with urinary urgency incontinence (UUI) symptoms.
The ProVIDE clinical study is a prospective, multi-center, double-blind controlled study to evaluate the safety, performance, and effectiveness of the ProVee System in patients with lower urinary tract symptoms secondary to BPH.